Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-13

Clinical Trial Update: A Randomized Controlled Trial (RCT) of Yiqi Huoxue Jiedu Formula Combined With Bacteriophages in the Treatment of Severe Pneumonia Caused by Drug-resistant Gram-negative Bacilli [EARLY_Phase 1]

View source ↗

Summary

An early-phase randomized trial evaluating Yiqi Huoxue Jiedu Formula with bacteriophages for severe pneumonia caused by drug-resistant Gram-negative bacilli; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bacteriophages
  • Yiqi Huoxue Jiedu Formula

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Pneumonia | EARLY_Phase 1 | Status: NOT_YET_RECRUITING